By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    healthcare cybersecurity
    4 Helpful Tips on How to Protect Your Medical Practice Against Cyber Attacks
    October 24, 2021
    Health Check Diagnosis Medical Condition Analysis Concept
    6 Health Woes With Online Remedies
    January 19, 2022
    Eight Things Men Should Know About the Male Menopause
    Eight Things Men Should Know About the Male Menopause
    April 24, 2022
    Latest News
    The 6 Most Common Injuries Resulting from Motorcycle Accidents
    January 30, 2023
    6 Essential Strategies for Improving Your Medical Practice
    January 25, 2023
    Staying Positive While Living with Mesothelioma
    January 24, 2023
    The Many Health Benefits of Being Outdoors
    January 17, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Ultraprocessed Foods Lead to Chronic Illnesses
    April 18, 2011
    Cancer/Cell Phone Connection Challenged
    June 7, 2011
    States Ranked by Percent Obese Highlights Pervasive Negative Trend
    July 11, 2011
    Latest News
    Why Is a Referenced Based Pricing Tool Necessary?
    February 3, 2023
    Simplifying the Genetic Testing Process: How At-Home Kits are Changing the Game
    January 25, 2023
    9 Hospitals That Have Introduced Green Initiatives
    February 1, 2023
    Why a Health Retreat Can Be the Best Medicine
    January 12, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Companion Diagnostics: More Targeted Medicine on the Horizon
Share
Sign In
Notification Show More
Latest News
Why Is a Referenced Based Pricing Tool Necessary?
Health care
struggling with addiction
6 Signs Someone You Know Is Struggling With Addiction
Addiction Addiction Recovery
regrow teeth naturally
Advances in Stem Cell Research Can Help Regrow Teeth Naturally
Dental health
air pollution and cancer
The Proven Links Between Air Pollution and Cancer
News
investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > Companion Diagnostics: More Targeted Medicine on the Horizon
BusinessDiagnosticsMedical InnovationsPolicy & LawTechnology

Companion Diagnostics: More Targeted Medicine on the Horizon

Shane Climie
Last updated: 2011/09/13 at 6:54 AM
Shane Climie
Share
6 Min Read
SHARE

It’s increasingly clear to anyone who deals with human health – from the bench biologist to the clinical oncologist – that humans are a heterogeneous species. As a result, a drug that works well in one individual may not work at all in another. Thus, the field of targeted (or personalized) medicine came about so doctors could optimize patient care through the use of genetic and biomarker testing.

It’s increasingly clear to anyone who deals with human health – from the bench biologist to the clinical oncologist – that humans are a heterogeneous species. As a result, a drug that works well in one individual may not work at all in another. Thus, the field of targeted (or personalized) medicine came about so doctors could optimize patient care through the use of genetic and biomarker testing. Such tests help identify patients who are (or who are not) most likely to respond to a given therapy. The field is often promoted as a way to get the “right drug to the right patient at the right dose.”

Correct dosing is critical because about 25 percent of all outpatient prescription drugs in the U.S. are taken by patients with genetic variations (specifically, polymorphisms) that affect absorption, metabolism or excretion of those drugs. Again, at risk of stating the obvious, human beings are heterogeneous.

Today, genetic tests are widely used to identify so-called “fast” and “slow” metabolizers of specific drugs and to adjust the dosage according to how long the drug may persist in an individual’s body. Other tests are used to determine whether patients carry drug targets that are sensitive to drugs (like Herceptin), or whether they harbor mutations that will render drugs inactive, either through resistance (from conditions like HIV) or via the presence of alternate pathways that can circumvent—or short circuit—the effects of a drug.

More Read

benefits of going on a health retreat

Why a Health Retreat Can Be the Best Medicine

Best Money-Saving Tips for Health Managers
HR Must Navigate Polarizing Views in Healthcare Workplaces
Should Hospitals Use SASE or Traditional Network Security?
Patient Tracking Systems: Improving Facilities for Patients and Medical Staff

These current tests can therefore reveal whether mutations have either a pharmacokinetic (i.e., drug metabolism) effect or a pharmacodynamic (i.e., drug target) effect.  Genetic and biomarker tests are also proving to be important in the management of many diseases, particularly those for which there are multiple therapeutic options and in those cases where the underlying pathology is caused by one of several possible mutations or other risk factors (e.g., breast cancer and diabetes).

While the U.S. Food & Drug Administration website lists approximately 115 biomarker tests associated with just over 100 approved drugs, researchers are moving quickly to add additional tools to the personalized medicine toolbox. One exciting new advance is the use of induced pluripotent stems cells (iPSC) to test drug response directly in cells isolated from individual patients. The idea is that skin cells, or blood cells, can be isolated from individual patients and used to generate iPSC, which are then induced to differentiate into multiple cell types such as neurons, cardiomyocytes, and hepatocytes.  Such cells harbor the genetic legacy of the patient from whom they were derived, and therefore a response (or non-response) of those cells to various drugs can be used to predict how a patient will respond.

The biotech firm, Cellular Dynamics International, which was co-founded by stem cell pioneer James Thomson, is now trying to undertake this approach. The firm is currently focused on the creation of iPSC-derived cardiomyocytes. However, it soon plans to add other cell types, including those from liver, brain and blood to the list.

So how “futuristic” is all of this? The good news is that many of the tools needed to realize the vision of personalized medicine are rapidly coming together. The combination of genomics, proteomics, stem cell biology, and other technologies are providing the information that is needed to drive the process. The challenge lies with the drugs themselves—the industry needs to apply the same tools more efficiently to guide the drug discovery process. Research, testing, approval, and application should work in tangent because the faster the next generation of drugs come into play and are FDA approved, the faster these new protocols of personalized medicine can be applied to save lives.

We also need to organize and apply the knowledge we’ve gained in genetic studies over the past ten years and apply this knowledge to evolving research. Effectively communicating the on-going research and applications of personalized medicine to the medical community will mean we’ll see designer drugs that are targeted to ever more specialized groups of patients. That day is on the near horizon, something that is of benefit to all of us, doctor and patient—the emergence of truly personalized medicine.

Are you involved in the discovery and/or development of companion diagnostics and/or drugs designed specifically for particular patient subsets? What do you see as the critical next steps to continue moving towards matching drugs with patients who will benefit most? Please share your thoughts with us here.

 

This post was originally published on the Popper and Co Blog. Shane Climie has more than 20 years of R&D and business development experience in the life sciences and pharmaceutical industry and is currently a principal at Popper and Co. 

TAGGED: biomarker testing, companion diagnostics, genetic testing, personalized medicine, targeted medicine

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Shane Climie September 13, 2011
Share this Article
Facebook Twitter Copy Link Print
Share
Previous Article Physician Leadership-What should We Expect?
Next Article How Much Do You Trust Your Employer?

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

Why Is a Referenced Based Pricing Tool Necessary?
Health care February 3, 2023
struggling with addiction
6 Signs Someone You Know Is Struggling With Addiction
Addiction Addiction Recovery February 2, 2023
regrow teeth naturally
Advances in Stem Cell Research Can Help Regrow Teeth Naturally
Dental health February 1, 2023
air pollution and cancer
The Proven Links Between Air Pollution and Cancer
News February 1, 2023

You Might also Like

Health care

Why Is a Referenced Based Pricing Tool Necessary?

February 3, 2023
The Future Of Medicine: How Immunotherapy Is Saving Lives
Technology

The Future Of Medicine: How Immunotherapy Is Saving Lives

January 26, 2023
medical practice and technology advancement
Technology

6 Essential Strategies for Improving Your Medical Practice

January 25, 2023
at-home genetic testing method kits
Global Healthcare

Simplifying the Genetic Testing Process: How At-Home Kits are Changing the Game

January 25, 2023
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?